Engages in priniting activities

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

Lantm��nnen AS-Faktor AB, a subsidiary of Lantm��nnen ek f��r, is a Swedish company located in Stockholm that provides scientific and technical research and development services.

Suzhou Yiben Life Technology Co., Ltd., established on 2019-08-28, Business scope includes technology development in the field of life science and technology;medicine,Medical device research and development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Engineering and Technology Research and Experimental Development;Import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Pharmacia & Upjohn AB is a private company headquartered in Stockholm, Sweden. The firm manufactures pharmaceutical drugs.

Fresenius Medical Care is a provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. It has a network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. It offers specialty pharmacy and laboratory services and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Bad Homburg, Frankfurt.

Sucampo GmbH, a subsidiary of Mallinckrodt Plc, is a Swiss company located in Zug that manufactures and distributes pharmaceuticals and health care products. It was founded by Ryuji Ueno and Sachiko Kuno. On December 29, 2010 Sucampo Pharmaceuticals, Inc., now a subsidiary of Mallinckrodt Plc acquired Sucampo GmbH for $120.00 million.

Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.. Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites more efficiently or to produce new ones as leads for drug discovery or as products for use in industry, and to identify drug targets in fungi for antifungal drug discovery. In 2002 the company hired John Talley to lead their antifungal drug discovery efforts, which at the time were focused on identifying small molecules that could inhibit fungal invasins, along with Mark Currie who had also worked at Searle division of Monsanto with Talley, and then had gone to Sepracor, and also Richard Bailey, who had run Monsanto's nutritional business. Currie directed the efforts that led to the discovery of linaclotide, which was based on an enterotoxin produced by some strains of Escherichia coli that cause traveler’s diarrhea.

Guangzhou Jingxiutang Pharmaceutical Co. Ltd., part of City of Guangzhou, is a company headquartered in Guangzhou, China, specializing in medicinal chemicals and botanical products.

R-Tech Ueno Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. It operates through the following business divisions: New Pharmaceutical Research and Development, Pharmaceutical Manufacture and Sale, and Pharmaceutical Development Support and Contract Manufacturing Services. The New Pharmaceutical Research and Development business provides development for unmet medical needs area, orphan drug area, and anti-aging area. The Pharmaceutical Manufacture and Sale business handles the manufacture and sale of Rescula Eye Drops for glaucoma and ocular hypertension. The Pharmaceutical Development Support and Contract Manufacturing Services business covers the manufacture and sale of AMITIZA capsules for chronic idiopathic constipation. It also accepts contract manufacturing of eye drops, liquid drugs and liquid-filled hard capsules. The company was founded by Ryuji Ueno and Sachiko Kuno in September 1989 and is headquartered in Tokyo, Japan.

Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France.

ADVOS is the world’s first method for the combined multi-organ support of liver, lung, kidney, and acid-base balance. Based on the principle of albumin dialysis, ADVOS allows extracorporeal fluid-based elimination of CO2, hepatic toxins, water-soluble and protein-bound nephrotoxins, as well as the correction of metabolic and respiratory acidosis. The ADVOS method works with typical dialysis accesses and flow rates and does not require any gas exchangers for CO2 elimination.

Pharmaceutical concern

Nanjing Xinsanxing Network Technology Co., Ltd., established on 2016-05-20, Business scope includes general items:Network technology service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Artificial intelligence public data platform;Professional repair of communication transmission equipment;Network and Information Security Software Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Drugrecure ApS, a subsidiary of Savara, Inc., is a Danish company that provides health care services.

Innoviva is committed to building long-lasting value and improving patient care, by partnering with companies that advance innovative therapies. Anchored by its respiratory assets, Innoviva blends a unique fusion of operational industry expertise and financial insight to create a solid foundation for capital returns—and carve a path towards a healthier world for patients.

ISHIHARA SANGYO KAISHA LTD. engages in the manufacture and sale of industrial chemicals. It operates through the following business segments: Inorganic Chemicals, Organic Chemicals and Other Businesses. The Inorganic Chemicals segment produces and sells titanium dioxide, functional and electronic materials, and other inorganic chemicals. The Organic Chemicals segment deals with organic intermediates such as agrochemicals and active pharmaceutical ingredients. The Other Businesses segment includes trading and construction business. The company was founded by Hiroichiro Ishihara on September 10, 1920 and is headquartered in Osaka, Japan.